TheEdgeResearch
Home / Stocks / SCNX

Scienture Holdings, Inc. (SCNX)

NASDAQ Healthcare Medical - Healthcare Information Services
$0.42 ▲ +2.03%
Market Cap
$17.0M
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
3.96
52-Wk Range
0.238-2.6
CEO
Shankar Hariharan
Country
US
Currency
USD

Scienture Holdings, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Commack, NY, US. The stock last traded at $0.42, up 2.03% on the session, giving a market capitalisation of $17.0M. On trailing twelve-month figures it carries a trailing P/E of -0.17, a net margin of -8761.3%. Its beta of 3.96 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.17
Price / Sales
35.50
Price / Book
0.00
EV / EBITDA
89.12
Gross margin
-20.7%
Operating margin
-3387.9%
Net margin
-8761.3%
Return on equity
Debt / equity
0.00
Current ratio
1.70
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
9
IPO date
2014-02-06
Headquarters
Commack, NY, US
About Scienture Holdings, Inc.

As a health services IT enterprise, TRxADE HEALTH, Inc. manages an online platform designed to facilitate transactions between licensed pharmaceutical wholesalers and healthcare providers. This digital marketplace enables wholesalers to distribute a broad spectrum of products and services, encompassing branded and generic drugs as well as other non-pharmaceutical items. Customers for these offerings span government organizations, hospitals, medical clinics, and independent pharmacies. The firm's corporate base is situated in Tampa, Florida.

Comparable companies

Scienture Holdings, Inc. is most often compared with the following Healthcare names:

AEONBFRGBOLTCINGEVGNIMNNSNSETNONTRAWXAIR
More research on SCNX
SCNX technical analysis SCNX TheEdge Score Compare against peers
Open full interactive analysis & DCF →